Yuki Nagata

830 citations
62 papers · 538 indexed · h-index 13
Topics
Parathyroid Disorders and Treatments (20 papers)Glaucoma and retinal disorders (10 papers)Bone health and treatments (10 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEJournal of Molecular Biology
Partner nations
JapanUnited States

In The Last Decade

Yuki Nagata

55 papers receiving 525 citations

Peers

Yuki Nagata
Comparison fields: 5 of 91
  • Nephrology 215
  • Molecular Biology 100
  • Oncology 100
  • Orthopedics and Sports Medicine 91
  • Pathology and Forensic Medicine 74
Replace Mansi Dalal with:
Mansi Dalal United States
Talia Diker‐Cohen Israel
Feng Bai China
Ayşen Akalın Türkiye
David Sherman United Kingdom
Giuseppe Palmiero Italy
Xiaofei Man China
Helena Gil‐Peña Spain
Yuki Nagata relative to Mansi Dalal United States Mansi Dalal's profile →
Citations per field
00.5×5.9×
Mansi Dalal · 1×
Citations per year

Countries citing papers authored by Yuki Nagata

Since Specialization
Citations

This map shows the geographic impact of Yuki Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Nagata more than expected).

Fields of papers citing papers by Yuki Nagata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Nagata. The network helps show where Yuki Nagata may publish in the future.

Co-authorship network of co-authors of Yuki Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Nagata. A scholar is included among the top collaborators of Yuki Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Nagata. Yuki Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 0
4 1
5 13
6 8
7 8
8 72
9 24
10 2
11 11
12 4
13 5
14 10
15 8
16 27
17 4
18 20
19 3
20 21

About Yuki Nagata

Yuki Nagata is a scholar working on Nephrology, Ophthalmology and Orthopedics and Sports Medicine, having authored 62 papers that have together received 538 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (20 papers), Glaucoma and retinal disorders (10 papers) and Bone health and treatments (10 papers). The work is most often cited by research in Nephrology (215 citations), Orthopedics and Sports Medicine (91 citations) and Ophthalmology (53 citations). Yuki Nagata has collaborated with scholars based in Japan and United States. Frequent co-authors include Yasuo Imanishi, Masanori Emoto, Katsuhito Mori, Masaaki Inaba, Shinsuke Yamada, Tomoaki Morioka, Masafumi Kurajoh, Shunsuke Nakakura, Minoru Inaba and Yoshiaki Kiuchi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026